{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:21:14Z","timestamp":1761488474442,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.intimp.2010.06.016","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T08:52:15Z","timestamp":1278492735000},"page":"1149-1152","source":"Crossref","is-referenced-by-count":33,"title":["Long-term intrathecal morphine and bupivacaine upregulate MOR gene expression in lymphocytes"],"prefix":"10.1016","volume":"10","author":[{"given":"Gabriele","family":"Campana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santi","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Raffaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2010.06.016_bb0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1034\/j.1399-6576.2001.450902.x","article-title":"Opioids in cancer and chronic non-cancer pain therapy-indications and controversies","volume":"45","author":"Breivik","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.intimp.2010.06.016_bb0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2950625","article-title":"Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors","volume":"295","author":"Chen","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.intimp.2010.06.016_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0020","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.94.4.1544","article-title":"Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia","volume":"94","author":"Sora","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.intimp.2010.06.016_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1525-1403.2007.00140.x","article-title":"Implantable intrathecal pumps for the treatment of noncancer chronic pain in elderly population: drug dose and clinical efficacy","volume":"11","author":"Raffaeli","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1016\/j.intimp.2010.06.016_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002508-199803000-00003","volume":"14","author":"Dahm","year":"1998","journal-title":"Clin J Pain"},{"key":"10.1016\/j.intimp.2010.06.016_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0885-3924(93)90083-8","article-title":"Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine","volume":"8","author":"Krames","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.intimp.2010.06.016_bb0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/bja\/57.4.424","article-title":"Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat","volume":"57","author":"Li","year":"1985","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.intimp.2010.06.016_bb0045","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)24553-0","article-title":"Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking","volume":"272","author":"Flores","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2010.06.016_bb0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0192-0561(96)00059-8","article-title":"Role of prolactin in the modulation of NK and LAK cell activity after short- or longterm morphine administration in neoplastic patients","volume":"18","author":"Provinciali","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0055","first-page":"475","article-title":"Biological consequences of long-term intrathecal administration of opioids","volume":"71","author":"Raffaeli","year":"2005","journal-title":"Minerva Anestesiol"},{"issue":"Supplement 3","key":"10.1016\/j.intimp.2010.06.016_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eujps.2009.08.002","article-title":"Long-term intrathecal morphine influence on major compounds of the endocrine system in elderly population","author":"Raffaeli","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1016\/j.intimp.2010.06.016_bb0065","first-page":"859","article-title":"SIAARTI recommendations for chronic noncancer pain. SIAARTI Chronic Non-Cancer Pain Study Group","volume":"72","author":"Ambrosio","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0070","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S026502150600038X","article-title":"Opioid-related side-effects after intrathecal morphine: a prospective, randomized, double-blind dose-response study","volume":"23","author":"Raffaeli","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1006\/bbrc.2000.4006","article-title":"Morphine upregulates mu opioid receptors of human and monkey lymphocytes","volume":"279","author":"Suzuki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2010.06.016_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-5728(97)00217-8","article-title":"Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action","volume":"83","author":"Mellon","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4615-1951-5_6","article-title":"Mitogenic activation of human T lymphocytes induces a high affinity morphine binding site","volume":"373","author":"Madden","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/00207459108985455","article-title":"Evaluation of NK and LAK cell activities in neoplastic patients during treatment with morphine","volume":"59","author":"Provinciali","year":"1991","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.intimp.2010.06.016_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03020942","article-title":"Intrathecal morphine suppresses NK cell activity following abdominal surgery","volume":"47","author":"Yokota","year":"2000","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.intimp.2010.06.016_bb0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther"},{"key":"10.1016\/j.intimp.2010.06.016_bb0105","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.intimp.2010.06.016_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/brbi.1999.0575","article-title":"Involvement of central mu- but not delta or kappa-opioid receptors in immunomodulation","volume":"14","author":"Nelson","year":"2000","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2010.06.016_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"[18] Sacerdote","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.intimp.2010.06.016_bb0120","doi-asserted-by":"crossref","first-page":"755s","DOI":"10.4049\/jimmunol.135.2.755","article-title":"Noradrenergic and peptidergic innervation of lymphoid tissue","volume":"135","author":"Felten","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(97)00218-X","article-title":"Opioid mediated effects on the immune system: sympathetic nervous system involvement","volume":"83","author":"Hall","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00001503-200410000-00015","article-title":"Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection","volume":"17","author":"Bernards","year":"2004","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00115550-200701000-00011","article-title":"Enhancement of proopiomelanocortin gene promoter activity by local anesthetics in a pituitary cell line","volume":"32","author":"Ikeda","year":"2007","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.intimp.2010.06.016_bb0140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1529-9430(02)00199-7","article-title":"Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine","volume":"2","author":"Deer","year":"2002","journal-title":"Spine J"},{"key":"10.1016\/j.intimp.2010.06.016_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2007.05.007","article-title":"Comparative analysis of mu-opioid receptor expression in immune and neuronal cells","volume":"188","author":"B\u00f6rner","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cellimm.2007.09.008","article-title":"Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression","volume":"252","author":"Finley","year":"2008","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0155","doi-asserted-by":"crossref","first-page":"43901","DOI":"10.1074\/jbc.M107543200","article-title":"Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site","volume":"276","author":"Kraus","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2010.06.016_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(94)00189-U","article-title":"The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine\/autocrine effects of the opioid","volume":"58","author":"Panerai","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2010.06.016_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biopha.2006.06.015","article-title":"Pain management: is opioid immunosuppression a clinical problem?","volume":"60","author":"Budd","year":"2006","journal-title":"Biomed Pharmacother"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:52:38Z","timestamp":1740250358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576910002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1567576910002031"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2010.06.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}